Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Certain substances can decrease or increase exploratory behavior in rodents.

Topical prostaglandin analogues may improve hair density in androgenetic alopecia, but more research is needed.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

Stress worsens Tourette symptoms by increasing allopregnanolone levels.

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Amygdalin in Persicae Semen may help treat hair loss by promoting hair growth and regulating key pathways.

Proteoglycans are vital for tissue growth and healing, with potential as treatment targets.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

Phenylephrine may help prevent hair loss from pulling on the hair roots.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Platelet-released growth factors can reduce inflammation in joint disease.

Upadacitinib effectively treats pyoderma gangrenosum.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Neurosteroids regulate synaptic inhibition in the spinal cord and may help manage spinal pain.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

PRP injections are safe but don't significantly improve Peyronie's Disease.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

AH-001 could be a safer and more effective treatment for hair loss.

Certain drugs can cause early hair growth in mice by affecting the nerves.